Abstract
The honeybee and its venom are unique among other flying Hymenoptera. The honeybee has entomologic and venom characteristics that make it both more docile and yet in ways more life-threatening than other Hymenoptera. These venom characteristics and composition make diagnosis and treatment for honeybee venom allergy more complicated, and honeybee is often involved in double positivity. Ultimately, diagnosis and perhaps treatment may improve as the role of venom component resolution is clarified. Honeybees are associated with a myriad of unusual reactions, both to the venom and to their various associated substances found in and around their habitat. Beekeepers represent a special population that are a high-risk group due to their inherent risk for stings and their propensity to be less likely to decrease risk. Finally, Africanized honeybees, the more aggressive relative, are a threat in the United States both to other hives and to humans, due to their aggressive nature. Mass envenomation requires specialized treatment and careful clinical consideration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Onbasi K, Onbasi O, Eminbeyli L, Kaynak C. Prevalence and alternative therapy methods for bee and wasp allergy in van. Allergy. 2008;63:246–7.
Charpin D, Birnbaum J, Lanteaume A, Vervloet D. Prevalence of allergy to Hymenoptera stings in different samples of the general population. J Allergy Clin Immunol. 1992;90:331–4.
Incorvaia C, Mauro M, Pastorello EA. Hymenoptera stings in conscripts. Allergy. 1997;52:680–1.
Jennings A, Duggan E, Perry IJ, Hourihane JOB. Epidemiology of allergic reactions to Hymenoptera stings in Irish school children. Pediatr Allergy Immunol. 2010;21:1166–70.
Prado M, Quiros D, Lomonte B. Mortality due to Hymenoptera stings in Costa Rica, 1985-2006. Pan Am J Public Health. 2009;25:389–93.
Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–64.
Coons BD, Quinn JM. Rates of honeybee sting hypersensitivity in San Antonio during honeybee colony collapse disorder. Ann Allergy Asthma Immunol. 2013;110:464.
Ratnieks FLW, Carreck NL. Clarity on honey bee collapse? Science. 2010;327:152–3.
Golden DBK, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA. 1989;262:240–4.
Novembre E, Cianferoni A, Bernardini R, et al. Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features. Clin Exp Allergy. 1998;28:834–8.
Fernandez J, Blanca M, Soriano V, Sanchez J, Juarez C. Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin Exp Allergy. 1999;29:1069–74.
Bjornsson E, Janson C, Plaschke P, Norrman E, Sjoberg O. Venom allergy in adult swedes: a population study. Allergy. 1995;50:800–5.
Sturm GJ, Bilo MB, Bonadonna P, et al. Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe. J Allergy Clin Immunol. 2012;130:817.
Bloch G. The social clock of the honeybee. J Biol Rhythms. 2010;25:301–17.
Greene A, Breisch NL. Avoidance of bee and wasp stings: an entomological perspective. Curr Opin Allergy Clin Immunol. 2005;5:337–41.
Weinstock GM, Robinson GE, Gibbs RA. Insights into the social insects from the genome of the honeybee Apismellifera. Nature. 2006;443:931–49.
Breed MD, Guzman-Novoa E, Hunt GJ. Defensive behavior of honey bees: organization, genetics, and comparisons with other bees. Annu Rev Entomol. 2004;49:271–98.
Schumacher MJ, Tveten MS, Egen NB. Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol. 1994;93:831–5.
Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet. 1996;348:301–2.
Hoffman DR, Jacobson RS. Allergens in Hymenoptera venom XII. How much protein is in a sting? Ann Allergy. 1984;52:276–8.
Van Vaerenbergh M, Debyser D, Devreese B, de Graaf DC. Exploring the hidden honeybee (Apismellifera) venom proteome by integrating a combinatorial peptide ligand library approach with FTMS. J Proteomics. 2014;99:169–78.
Mustafa FB, Ng FS, Nguyen TH, Lim LH. Honeybee venom secretory phospholipase A2 induces leukotriene production but not histamine release from human basophils. Clin Exp Immunol. 2008;151:94–100.
Dudler T, Scheider T, Annand RR, et al. Antigenic surface of bee venom phospholipase A2. J Immunol. 1994;152:5514–22.
Kohler J, Blank S, Muller S, et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014;133:1383–9.
Hofmann SC, Pfender N, Weckesser S, Huss-Marp J, Jakob T. Added value of IgE detection to rApi m 1 and r Ves v 5 in patients with Hymenoptera venom allergy. J Allergy Clin Immunol. 2011;127:265–7.
Korosec P, Valenta R, Mittermann I, et al. Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy. J Allergy Clin Immunol. 2011;128:671–3.
Mittermann I, Zidarn M, Silar M, et al. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol. 2010;125:1300–7. e3
Sturm GJ, Hemmer W, Hawranek R, et al. Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immunol. 2011;128:247–8.
Hofmann SC, Pfender N, Weckesser S, et al. Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy. J Allergy Clin Immunol. 2011;128:248.
Jakob T, Kohler J, Blank S, et al. Comparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant-negative patients with bee venom allergy. J Allergy Clin Immunol. 2012;130:276–8.
Vetter RS, Visscher PK, Camazine S. Mass envenomations by honey bees and wasps. West J Med. 1999;170:223–7.
Jin C, Focke M, Leonard R, et al. Reassessing the role of hyaluronidase in yellow jacket venom allergy. J Allergy Clin Immunol. 2010;125:184–90.
Soldatova LN, Crameri R, Gmachi M, et al. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J Allergy Clin Immunol. 1998;101:691–8.
Markovic-Housley Z, Miglierini G, Soldatova L, et al. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure. 2000;8:1025–35.
de Graaf DC, Aerts M, Danneels E, Devreese B. Bee, wasp, and ant venomics pave the way for a component-resolved diagnosis of sting allergy. J Proteomics. 2009;72:145–54.
Schmidt JO, Blum MS, Overal WL. Comparative enzymology of venom from stinging Hymenoptera. Toxicon. 1986;24:907–21.
Hoffman DR. Hymenoptera venoms: composition, standardization, stability. In: Levin MI, Lockey RF, editors. Monograph on insect allergy. 4th ed. Pittsburgh: Dave Lambert Associates; 2003. p. 37–53.
Kemeny DM, Harries MG, Youlten LJ, et al. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy. J Allergy Clin Immunol. 1983;71:505–14.
Blank S, Seismann H, Bockish B, et al. Identification, recombinant expression and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m5 and Ves v3. J Immunol. 2010;184:5403–13.
Blank S, Seismann H, Michel Y, et al. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts. Allergy. 2011;66:1322–9.
Van Vaerenbergh M, De Smet L, Rafei-Shamsabadi D, et al. IgE recognition of chimeric isoforms of the honeybee (Apismellifera) venom allergen Api m 10 evaluated by protein array technology. Mol Immunol. 2015;63:449–55.
Baker TW, Forester JP, Johnson ML, Stolfi A, Stahl MC. The HIT study: Hymenoptera identification test—how accurate are people at identifying stinging insects? Ann Allergy Asthma Immunol. 2014;114:267–70.
Golden DBK, Moffitt J, Nicklas RA. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127:852–4.
Georgitis J, Reisman R. Venom skin tests in insect-allergic and insect non-allergic populations. J Allergy Clin Immunol. 1985;76:803–7.
Brown TC, Tankersley MS. The sting of the honeybee: an allergic perspective. Ann Allergy Asthma Immunol. 2011;107:463–71.
Golden DBK. New directions in diagnostic evaluation of insect allergy. Curr Opin Allergy Clin Immunol. 2014;14:334–9.
Rueff F, Jappe U, Przybilla B. Standards and pitfalls of in-vitro diagnostics of Hymenoptera venom allergy. Hautarzt. 2010;61:938–45.
Sturm GJ, Jin C, Kranzelbinder B, et al. Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy. PLoS One. 2011;6:e20842.
Blank S, Seismann H, McIntyre M, et al. Vitellogenins are new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apismellifera and Vespula Vulgaris venom. PLoS One. 2013;8:e62009.
King TP, Joslyn A, Kochoumian L. Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets. J Allergy Clin Immunol. 1985;75:621–8.
Ebo DG, Faber M, Sabato V, et al. Component-resolved diagnostics of wasp (yellow jacket) venom allergy. Clin Exp Allergy. 2012;43:255–61.
Korosec P, Valenta R, Mittermann I, et al. High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy. J Allergy Clin Immunol. 2012;129:1406–8.
Muller U, Schmid-Grendelmeier P, Hausman O, Helbling A. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy. 2012;67:1069–73.
Eberlein B, Krischan L, Darsow U, Ollert M. Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol. 2012;130:155–61.
Korosec P, Erzen R, Silar M, et al. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy. 2009;39:1730–7.
Golden DBK. Advances in diagnosis and management of insect sting allergy. Ann Allergy Asthma Immunol. 2013;111:84–9.
Golden DBK, Kelly D, Hamilton RG, et al. Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom. Ann Allergy Asthma Immunol. 2009;102:47–50.
Stritzke AI, Eng PA. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. Allergy. 2013;43:950–5.
Muller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol. 1991;87:702–9.
Muller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol. 1992;89:529–35.
Lerch E, Muller UR. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol. 1998;101:606–12.
Golden GBK, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol. 1998;101:298–305.
Birnbaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy. 1993;23:226–30.
Stoevesandt J, Hosp C, Kerstan A, Trautmann A. Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phase. J Dtsch Dermatol Ges. 2014;12:244–55.
Korosec P, Ziberna K, Silar M, et al. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy. Clin Exp Allergy. 2015;45:1579–89.
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466–9.
Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol. 2010;125:569–74. e1-7
Rueff F, Przybilla B, Bilo MB, et al. Predictors of side effects during the build-up phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;126:105–11.
Rueff F, Vos B, Oude Elberink J, et al. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. Clin Exp Allergy. 2014;44:736–46.
Kosnik M, Silar M, Bajrovic N, et al. High sensitivity of basophils predicts side effects in venom immunotherapy. Allergy. 2005;60:1401–6.
Erzen R, Kosnik M, Silar M, Korosec P. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study. Allergy. 2012;67:822–30.
Kucera P, Cvackova M, Hulikova K, et al. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy. J Investig Allergol Clin Immunol. 2010;20:110–6.
Rueff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol. 2001;108:1027–32.
Reisman RE, Livingston A. Venom immunotherapy: 10 years of experience with administration of single venoms and 50 mg maintenance doses. J Allergy Clin Immunol. 1992;89:1189–95.
Houliston L, Nolan R, Noble V, et al. Honeybee venom immunotherapy in children using a 50-mg maintenance dose. J Allergy Clin Immunol. 2011;127:98–9.
Goldberg A, Confino-Cohen R. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious. J Allergy Clin Immunol. 2001;107:902–6.
Cavallucci E, Ramondo S, Renzetti A, et al. Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence. J Investig Allergol Clin Immunol. 2010;20:63–8.
Goldberg A, Confino-Cohen R. Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals. Ann Allergy Asthma Immunol. 2007;99:352–7.
Lessof MH, Sobotka AK, Lichtenstein LM. Effects of passive antibody in bee venom anaphylaxis. Johns Hopkins Med J. 1978;142:1–7.
Muller UR, Morris T, Bischof M, Friedli H, Skarvil F. Combined active and passive immunotherapy in honeybee-sting allergy. J Allergy Clin Immunol. 1986;78:115–22.
Severino MG, Cortellini G, Bonadonna P, et al. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:44–8.
Rueff F, Bilo MB, Jutel M, et al. Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy. J Allergy Clin Immunol. 2009;123:272–3.
Galera C, Soohun N, Zankar N, et al. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment with omalizumab. J Investig Allergol Clin Immunol. 2009;19:225–9.
da Silva EN, Randall KL. Omalizumab mitigates anaphylaxis during ultra-rush honey bee venom immunotherapy in monoclonal mast cell activation syndrome. J Allergy Clin Immunol. 2013;133:687–8.
Kosnik M, Korosec P. Venom immunotherapy: clinical efficacy, safety and contraindications. Expert Rev Clin Immunol. 2015;11:877–84.
Hsu CY, Chiang WC, Weng TI, et al. Laryngeal edema and anaphylactic shock after topical propolis use for acute pharyngitis. Am J Emerg Med. 2004;22:432–3.
Katayama M, Aoki M, Kawana S. Case of anaphylaxis caused by ingestion of royal jelly. J Dermatol. 2008;35:222–4.
Brown TC. Reactions to honeybee stings: an allergic prospective. Curr Opin Allergy Clin Immunol. 2013;13:365–71.
Shin YS, Liu JN, Hur G-Y, et al. Clinical features and the diagnostic value of component allergen-specific IgE in Hymenoptera venom allergy. Allergy Asthma Immunol Res. 2012;4:284–9.
Sturm GJ, Kranzelbinder B, Schuster C, et al. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014;133:1635–43. e1631
Vezir E, Kaya A, Toyran M, et al. Anaphylaxis/angioedema caused by honey ingestion. Allergy Asthma Proc. 2014;35:71–4.
Ades TB, editor Apitherapy. American Cancer Society complete guide to complementary and alternative cancer therapies. 2nd ed. Atlanta: American Cancer Society; 2009. p. 704–8. ISBN 9780944235713.
Cassileth BR (2011). The complete guide to complementary therapies in cancer care: essential information for patients, survivors and health professionals. World Scientific. pp. 221–. ISBN 978–981–4335–66-9
Pitsios C, Chliva C, Mikos N, et al. Bee pollen sensitivity in airborne pollen allergic individuals. Ann Allergy Asthma Immunol. 2006;97(5):703–6.
Martín-Muñoz MF, Bartolome B, Caminoa M, et al. Bee pollen: a dangerous food for allergic children. Identification of responsible allergens. Allergol Immunopathol (Madr). 2010;38(5):263–5. doi:10.1016/j.aller.2009.12.003.
“Bee pollen benefits and side effects". WebMD. Retrieved April 16, 2014. Natural Medicines Comprehensive Database: "Bee Pollen."
Greenberger PA. Bee pollen-induced anaphylactic reaction in an unknowingly sensitized subject. Ann Allergy Asthma Immunol. 2001;86(2):239–42.
Akiyasu T, Paudyal B, Paudyal P, et al. A case report of acute renal failure associated with bee pollen contained in nutritional supplements. Ther Apher Dial. 2010;14(1):93–7. doi:10.1111/j.1744-9987.2009.00707.x.
Ventura MT, Viola M, Calogiuri G, et al. Hypersensitivity reactions to complementary and alternative medicine products. Curr Pharm Des. 2006;12(26):3393–9.
Matos D, Serrano P, Menezes Brandão F, et al. A case of allergic contact dermatitis caused by propolis-enriched honey. Contact Dermatitis. 2015;72(1):59–60. doi:10.1111/cod.12297.
Münstedt K, Hellner M, Hackethal A, et al. Contact allergy to propolis in beekeepers. Allergol Immunopathol (Madr). 2007;35(3):95–100.
Walgrave SE, Warshaw EM, Glesne LA, et al. Allergic contact dermatitis from propolis. Dermatitis. 2005;16(4):209–15. Review
Giusti F, Miglietta R, Pepe P, et al. Sensitization to propolis in 1255 children undergoing patch testing. Contact Dermatitis. 2004;51(5–6):255–8.
Rajpara S, Wilkinson MS, King CM, et al. The importance of propolis in patch testing—a multicentre survey. Contact Dermatitis. 2009;61(5):287–90. doi:10.1111/j.1600-0536.2009.01629.x.
Fransway AF, Zug KA, Belsito DV, et al. North American contact dermatitis group patch test results for 2007-2008. Dermatitis. 2013;24(1):10–21. doi:10.1097/DER.0b013e318277ca50.
Lombardi C, Bottello M, Caruso A, et al. Allergy and skin diseases in musicians. Eur Ann Allergy Clin Immunol. 2003;35(2):52–5.
Propolis: hypersensitivity reactions. Prescrire Int. 2010;19(108):170.
Cho R, Lee JD, Cho SH. Systemic contact dermatitis from propolis ingestion. Ann Dermatol. 2011;23:85–8.
Bauer L, Kohlich A, Hirschwehr R, et al. Food allergy to honey: pollen or bee products? Characterization of allergenic proteins in honey by means of immunoblotting. J Allergy Clin Immunol. 1996;97(1 Pt 1):65–73.
Pasolini G, Semenza D, Capezzera R, et al. Allergic contact cheilitis induced by repeated contact with propolis-enriched honey. Contact Dermatitis. 2004;50(5):322–3.
Helbling A, Peter C, Berchtold E, et al. Allergy to honey: relation to pollen and honey bee allergy. Allergy. 1992;47:41–9.
Lombardi C, Senna GE, Gatti B, et al. Allergic reactions to honey and royal jelly and their relationship with sensitization to compositae. Allergol Immunopathol (Madr). 1998;26(6):288–90.
Takahama H, Shimazu T. Food-induced anaphylaxis caused by ingestion of royal jelly. J Dermatol. 2006;33:424–6.
Thien FC, Leung R, Baldo BA, et al. Asthma and anaphylaxis induced by royal jelly. Clin Exp Allergy. 1996;26:216–22.
Leung R, Thien FC, Baldo B, Czamy D. Royal jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. J Allergy Clin Immunol. 1995;96:1004–7.
Bullock RJ, Rohan A, Straatmans JA. Fatal royal jelly-induced asthma. Med J Aust. 1994;160:44.
Leung R, Ho A, Chan J, et al. Royal jelly consumption and hypersensitivity in the community. Clin Exp Allergy. 1997;27(3):333–6.
Vila L, Bartolome B, Moreno A, et al. Cross-reactivity between royal jelly and Dermato-phagoidespteronyssinus. J Allergy Clin Immunol Pract. 2013;1(2):200–1. doi:10.1016/j.jaip.2013.01.003.
Lucente P, Cavalli M, Vezzani C, et al. Contact cheilitis due to beeswax. Contact Dermatitis. 1996;35(4):258.
Bousquet J, Menardo J-L, Aznar R, et al. Clinical and immunologic survey in beekeepers in relation to their sensitization. J Allergy Clin Immunol. 1984;73:332–40.
Richter AG, Nightingale P, Huissoon AP, et al. Risk factors for systemic reactions to bee venom in British beekeepers. Ann Allergy Asthma Immunol. 2011;106:159–63.
Munstedt K, Hellner M, Winter D, et al. Allergy to bee venom in beekeepers in Germany. J Investig Allergol Clin Immunol. 2008;18:100–5.
Müller U. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol. 2005;5:343–7.
Eich-Wanger C, Müller U. Bee sting allergy in beekeepers. Clin Exp Allergy. 1998;28:1292–8.
Light WC, Reisman RE, Wypych JI, et al. Clinical and immunological studies of beekeepers. Clin Allergy. 1975;5:389–95.
Münstedt K, Kalder M. Contact allergy to propolis in beekeepers. Allergol Immunopathol (Madr). 2009;37(6):298–301.
Garrido Fernández S, Arroabarren Alemán E, García Figueroa BE, et al. Direct and airborne contact dermatitis from propolis in beekeepers. Contact Dermatitis. 2004;50(5):320–1.
Reisman RE. Unusual reactions to insect stings. Curr Opin Allergy Clin Immunol. 2005;5(4):355–8.
Mytas DZ, Stougiannos PN, Zairis MN, et al. Acute anterior myocardial infarction after multiple bee stings. A case of Kounis syndrome. Int J Cardiol. 2009;134(3):e129–31. doi:10.1016/j.ijcard.2008.01.050.
Ceyhan C, Ercan E, Tekten T, et al. Myocardial infarction following a bee sting. Int J Cardiol. 2001;80:251–3.
Boz C, Velioglu S, Ozmenoglu M. Acute disseminated encephalomyelitis after bee sting. Neurol Sci. 2003;23:313–5.
Goldstein NP, Rucker W, Klass DW. Encephalopathy and papilledema after bee sting. JAMA. 1964;188:1083–4.
Ross AT. Peripheral neuritis: allergy to honeybee stings. J Allergy. 1939;10:382–4.
Rytand DA. Onset of nephrotic syndrome during a reaction to bee sting. Stanford Med Bull. 1955;13:224–33.
Venters HD, Vernier RL, Worthen HG, Good RA. Bee sting nephrosis: a study of the immunopathologic mechanisms. Am J Dis Child. 1961;102:688–9.
Lam SM. Acute pulmonary hemorrhage following a honeybee sting: a case report. J Microbiol Immunol Infect. 1998;31:133–6.
Tanphaichitr VS, Tuchinda M. Severe thrombocytopenic purpura following a bee sting. Ann Allergy. 1982;49:229–31.
Daisley H. Acute Haemorrhagic pancreatitis following multiple stings by Africanized bees in Trinidad. Trans R Soc Trop Med Hyg. 1998;92(1):71–2.
Szalanski AL, McKern JA. Multiplex PCR-RFLP diagnostics of the African honey bee (Hymenoptera: Apidae). Sociobiology. 2007;50:939–45.
Collins AM, Rinderer TE, Harbo JR, Bolton AB. Colony defense by Africanized and European honey bees. Science. 1982;218:72–4.
Nelson D, Collins AM, Hellmich RL, et al. Biochemical and immunochemical comparison of Africanized and European honey bee venoms. J Allergy Clin Immunol. 1990;85:80–5.
Schumacher MJ, Schmidt JO, Egen NB, Dillon KA. Biochemical variability of venoms from individual European and Africanized honey bees (Apismellifera). J Allergy Clin Immunol. 1992;90:59–65.
Schumacher MJ, Schmidt JO, Egen NB, Lowry JE. Quantity analysis, and lethality of European and Africanized honey bee venoms. Am J Trop Med Hyg. 1990;43:79–86.
Park R. Bee and Hymenoptera stings. October 13, 2005. http://emedicine.com/emerg/topic55.html. Accessed 10 March 2006.
Schumacher M, Egen N. Significance of Africanized bees for public health: a review. Arch Intern Med. 1995;155:2038–44.
Daher Ede F, da Silva Jr GB, Bezerra GP, Pontes LB, Martins AM, Guimaraes JA. Acute renal failure after massive honeybee stings. Rev Inst Med Trop Sao Paulo. 2003;45:45–50.
Ferreira Jr RS, Almeida RAMB, Barraviera SRCS, Barraviera B. Historical perspective and human consequences of Africanized bee stings in the Americas. J Toxicol Environ Health B Crit Rev. 2012;15(2):97–108.
Jones RG, Corteling RL, Bhogal G, Landon J. A novel fab-based antivenom for the treatment of mass bee attacks. Am J Trop Med Hyg. 1999;61:361–6.
Winston ML. The Africanized “killer” bee: biology and public health. Q J Med. 1994;87:263–7.
Kaplan J. What’s buzzing with Africanized honeybees? Agribiol Res. 2004;52:4–8. http://www.ars.usda.gov/is/AR/archive/mar04/bees0304.html
McKenna WR. Characteristics of multiple-massive honey bee sting cases. J Allergy Clin Immunol. 1994;93:224.
Silva GA, Pires KL, Soares DC. RRH: envenoming syndrome due to 200 stings from Africanized honeybees. Rev Inst Med Trop Sao Paulo. 2013;55(1):61–4.
Sherman R. What physicians should know about Africanized honeybees. West J Med. 1995;163:541–6.
McKenna WR. Africanized honey bees. In: Levin MI, Lockey RF, editors. Monograph on insect allergy. 4th ed. Pittsburgh: Dave Lambert Associates; 2003. p. 27–35.
Almeida RA, Olivo TE, Mendes RP, et al. Africanized honeybee stings: how to treat them. Rev Soc Bras Med Trop. 2011;44(6):755–61.
Díaz-Sánchez CL, Lifshitz-Guinzberg A, Ignacio-Ibarra G, et al. Survival after massive (>2000) Africanized honeybee stings. Arch Intern Med. 1998;158(8):925–7.
Murray JA. A case of multiple bee stings. Cent Afr J Med. 1964;10:249–51.
McKenna WR. Killer bees, what the allergist should know. Ped Asthma, Allergy Immunol. 1992;6:275–85.
McKenna WR. Africanized honey bees AKA “killer bees”. San Antonio MD. 1992;2:8–9,12.
Azevedo RV, Paiva RB, Ades F, et al. Poisoning syndrome due to 2,000 stings of africanized honeybees. Rev Bras Ter Intensiva. 2006;18(1):99–103.
Betten DP, Richardson WH, Tong TC, et al. Massive honey bee envenomation-induced rhabdomyolysis in an adolescent. Pediatrics. 2006;117(1):231–5.
Lovecchio F, Cannon RD, Algier J, et al. Bee swarmings in children. Am J Emerg Med. 2007;25(8):931–3.
Mitchell A. Africanized killer bees. Crit Care Nurse. 2006;26(3):23–31.
MejíaVélez G (2010). "Insuficiencia renal agudaporpicaduramúltiple de abejasafricanizadas. Comunicación de 43 casos" [Acute renal failure due to multiple stings by Africanized bees. Report on 43 cases]. Nefrologia :publicacionoficial de la Sociedad Espanola Nefrologia. 30(5):531–8. doi:10.3265/Nefrologia.pre2010.May.10269. PMID 20613852.
Tunget CL, Clark RF. Invasion of the “killer” bees: separating fact from fiction. Postgrad Med. 1993;94:92–94, 97–98, 101–102.
Greenberg MI, Hendrickson RG, Silverberg M, et al. Greenberg’s text atlas of emergency medicine. Philadelphia, Pa: Lippincott; 2005.
Bresolin NL, Carvalho FC, Goes JC, Fernandes V, Barotto AM. Acute renal failure following massive attack by Africanized bee stings. Pediatr Nephrol. 2002;17:625–7.
Daher EF, Silva Jr GB, Bezerra GP, Pontes LB, Martins AMC, Guimarães JA. Acute renal failure after massive honeybee stings. Rev Inst Med Trop São Paulo. 2003;45:45–50.
Daher EF, Oliveira RA, Silva LSV, Silva EMB, Morais TP. Insuficiência renal agudaporpicada de abelhas: relato de casos. Rev Soc Bras Med Trop. 2009;42:209–12.
França FO, Benvenuti LA, Fan HW, Dos Santos DR, Hain SH, Picchi-Martins FR, et al. Severe and fatal mass attacks by "killer" bees (Africanized honey bees—Apismelliferascutellata) in Brazil: clinicopathological studies with measurement of serum venom concentrations. Q J Med. 1994;87:269–82.
McKenna WR, Hess B. Massive Honeybee envenomation and plasmapheresis. Abstract #2388 Annual AAAAI Meeting. 2003.
Humblet Y, Sonnet J, Van Ypersele de Strihou C. Bee stings and acute tubular necrosis. Nephron. 1982;31:187–8.
Mejia G, Arbelaez M, Henao JE, et al. Acute renal failure due to multiple stings by Africanized bees. Ann Intern Med. 1986;104:210–1.
Patrick A, Roberts L, Poon-King P, et al. Acute renal failure due to multiple stings by Africanized bees. Report of the first case in Trinidad. West Indian Med J. 1987;36:43–4.
Munoz-Arizpe R, Velasquez-Jones L, Romero-Navarro B, et al. Acute kidney failure due to stings by Africanized bees. Bol Med Hosp Infant Mex. 1992;49(6):388–90.
Munoz-Arizpe R, Valencia-Espinoza L, Velasquez-Jones L, et al. Africanized bee stings and pathogenesis of acute renal failure. Nephron. 1992;61(4):478.
Gabriel DP, Rodriguez Jr AG, Barsante RC, et al. Severe acute renal failure after massive attack of Africanized bees. Nephrol Dial Transplant. 2004;19(10):2680.
Grisotti LS, Mendez GE, Castro I, Baptista MA, Alves VA, Yu L, Burdmann EA. Mechanisms of bee venom induced acute renal failure. Toxicon. 2006;48:44–54.
Mitchell A. Africanized killer bees: a case study. Crit Care Nurse. 2006;26(3):23–6, 28–31.
Kolecki P. Delayed toxic reaction following massive bee envenomation. Ann Emerg Med. 1999;33:114–6.
Clark R, Schneir A. Arthropod bits and bee stings. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency medicine: a comprehensive study guide. 6th ed. New York, NY: McGraw-Hill; 2004. p. 1190–3.
Beccari M. Dialysis or plasmapheresis for acute renal failure due to Africanized honeybee stings. Arch Intern Med. 1999;159:1255–6.
Schmidt JO. Allergy to venomous insects. In: Graham JM, editor. The hive and the honey bee. Hamilton IL: Dadant and Sons; 1992. p. 1223–6.
Becerril-Ángeles M, Núñez-Velázquez M, Arias-Martìnez MI, et al. Mortality related to honey-bee stings in Mexico from 1988 to 2009. Rev Alerg Mex. 2013;60(2):58–62.
Taylor OR. Health problems associated with African bees. Ann Intern Med. 1986;104:267–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
McKenna, W.R., Brown, T.C. (2017). Unique Aspects of Bee Allergy and Reactions. In: Freeman, T., Tracy, J. (eds) Stinging Insect Allergy. Springer, Cham. https://doi.org/10.1007/978-3-319-46192-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-46192-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46190-8
Online ISBN: 978-3-319-46192-2
eBook Packages: MedicineMedicine (R0)